Table 1.
Demographics divided into group A and B and subgroups
| Demographics | n |
| No. of patients | 439 |
| No. of females patients | 246 |
| Age (years) | 72.89 ± 11.99 |
| No. of male patients | 193 |
| Age (years) | 72.07 ± 12.12 |
| Bilateral treatment | 167 |
| Unilateral treatment | 268 |
| No. of eyes operated total | 602 |
| No. of eyes excluded due to intraoperative conversion to other surgery | 18 |
| → Trabeculectomy with ologen and MMC 0.02% | 9 |
| → Trabeculectomy with ologen and MMC 0.02% and Phaco | 7 |
| → Viscocanalostomy | 2 |
| No. of studied eyes | 584 |
| Group A | n |
| Canaloplasty | 262 |
| → Subgroup (Advanced POAG – target IOP ≤ 16 mmHg) | 172 |
| • MD – dB | 14.31 ± 3.56 |
| • IOP – mmHg | 19.15 ± 6.42 |
| • Antiglaucoma agents | 2.71 ± 0.95 |
| • DCVA – Snellen | 0.58 ± 0.29 |
| → Subgroup (Moderate POAG – target IOP ≤ 18 mmHg) | 51 |
| • MD – dB | 7.31 ± 3.22 |
| • IOP – mmHg | 20.66 ± 5.04 |
| • Antiglaucoma agents | 2.77 ± 0.94 |
| • DCVA – Snellen | 0.79 ± 0.21 |
| → Subgroup (Early POAG – target IOP ≤ 21 mmHg) | 39 |
| • MD – dB | 4.22 ± 4.13 |
| • IOP – mmHg | 21.25 ± 5.67 |
| • Antiglaucoma agents | 2.69 ± 1.21 |
| • DCVA – Snellen | 0.64 ± 0.21 |
| Group B | n |
| Canaloplasty with Phacoemulsification | 322 |
| → Subgroup (Advanced POAG – target IOP ≤ 16 mmHg) | 212 |
| • MD – dB | 16.11 ± 4.42 |
| • IOP – mmHg | 19.39 ± 7.49 |
| • Antiglaucoma agents | 2.70 ± 0.95 |
| • DCVA – Snellen | 0.53 ± 0.25 |
| → Subgroup (Moderate POAG – target IOP ≤ 18 mmHg) | 51 |
| • MD – dB | 8.01 ± 3.01 |
| • IOP – mmHg | 19.54 ± 5.90 |
| • Antiglaucoma agents | 2.32 ± 1.02 |
| • DCVA – Snellen | 0.56 ± 0.26 |
| → Subgroup (Early POAG – target IOP ≤ 21 mmHg) | 39 |
| • MD – dB | 5.06 ± 2.17 |
| • IOP – mmHg | 19.42 ± 7.32 |
| • Antiglaucoma agents | 2.40 ± 1.06 |
| • DCVA – Snellen | 0.55 ± 0.23 |
POAG = primary open angle glaucoma; IOP = intraocular pressure; MD = mean deviation; dB = decibels; DCVA = distance corrected visual acuity